Patents by Inventor John Steven Garrett

John Steven Garrett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY
    Publication number: 20160106805
    Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
    Type: Application
    Filed: November 2, 2015
    Publication date: April 21, 2016
    Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L. Chandrashekar
  • Polymeric delivery formulations of leuprolide with improved efficacy
    Patent number: 9254307
    Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: February 9, 2016
    Assignee: Tolmar Therapeutics, Inc.
    Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L. Chandrashekar
  • POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY
    Publication number: 20150150937
    Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
    Type: Application
    Filed: February 11, 2015
    Publication date: June 4, 2015
    Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L. Chandrashekar
  • Polymeric delivery formulations of leuprolide with improved efficacy
    Patent number: 8486455
    Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: July 16, 2013
    Assignee: Tolmar Therapeutics, Inc.
    Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L. Chandrashekar
  • POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY
    Publication number: 20100234305
    Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
    Type: Application
    Filed: May 20, 2010
    Publication date: September 16, 2010
    Applicant: QLT USA, INC.
    Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L. Chandrashekar
  • POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY
    Publication number: 20100226954
    Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
    Type: Application
    Filed: May 20, 2010
    Publication date: September 9, 2010
    Applicant: QLT USA, INC.
    Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L. Chandrashekar
  • Polymeric delivery formulations of leuprolide with improved efficacy
    Publication number: 20040229912
    Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
    Type: Application
    Filed: June 21, 2004
    Publication date: November 18, 2004
    Applicant: Atrix Laboratories, Inc.
    Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L. Chandrashekar
  • Polymeric delivery formulations of leuprolide with improved efficacy
    Patent number: 6773714
    Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
    Type: Grant
    Filed: February 24, 2003
    Date of Patent: August 10, 2004
    Assignee: Atrix Laboratories, Inc.
    Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L. Chandrashekar
  • Polymeric delivery formulations of leuprolide with improved efficacy
    Publication number: 20030133964
    Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
    Type: Application
    Filed: February 24, 2003
    Publication date: July 17, 2003
    Applicant: Atrix Laboratories, Inc.
    Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L. Chandrashekar
  • Polymeric delivery formulations of leuprolide with improved efficacy
    Patent number: 6565874
    Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: May 20, 2003
    Assignee: Atrix Laboratories
    Inventors: Richard L. Dunn, John Steven Garrett, Harish Ravivarapu, Bhagya L Chandrashekar